Report Detail

Pharma & Healthcare Global Afatinib Maleate Tablets Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4772936
  • |
  • 06 November, 2026
  • |
  • Global
  • |
  • 100 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Afatinib Maleate Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Afatinib Maleate Tablets market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Afatinib Maleate Tablets market size and forecasts, in consumption value ($ Million), 2021-2032
Global Afatinib Maleate Tablets market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Afatinib Maleate Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Afatinib Maleate Tablets market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Afatinib Maleate Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Afatinib Maleate Tablets market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim International GmbH, Kelun-Kazpharm, Hansoh Pharmaceuticak, Qilu Pharmaceutical, Chia Tai-Tianqing, Yangtze River Pharm, Beacon Pharmaceuticals, Qingfeng Medicine Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Afatinib Maleate Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
20mg
30mg
40mg
50mg
Market segment by Application
Hospital
Clinic
Others
Market segment by players, this report covers
Boehringer Ingelheim International GmbH
Kelun-Kazpharm
Hansoh Pharmaceuticak
Qilu Pharmaceutical
Chia Tai-Tianqing
Yangtze River Pharm
Beacon Pharmaceuticals
Qingfeng Medicine Group
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Afatinib Maleate Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Afatinib Maleate Tablets, with revenue, gross margin, and global market share of Afatinib Maleate Tablets from 2021 to 2026.
Chapter 3, the Afatinib Maleate Tablets competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Afatinib Maleate Tablets market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Afatinib Maleate Tablets.
Chapter 13, to describe Afatinib Maleate Tablets research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Afatinib Maleate Tablets by Type
    • 1.3.1 Overview: Global Afatinib Maleate Tablets Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Afatinib Maleate Tablets Consumption Value Market Share by Type in 2025
    • 1.3.3 20mg
    • 1.3.4 30mg
    • 1.3.5 40mg
    • 1.3.6 50mg
  • 1.4 Global Afatinib Maleate Tablets Market by Application
    • 1.4.1 Overview: Global Afatinib Maleate Tablets Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Afatinib Maleate Tablets Market Size & Forecast
  • 1.6 Global Afatinib Maleate Tablets Market Size and Forecast by Region
    • 1.6.1 Global Afatinib Maleate Tablets Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Afatinib Maleate Tablets Market Size by Region, (2021-2032)
    • 1.6.3 North America Afatinib Maleate Tablets Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Afatinib Maleate Tablets Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Afatinib Maleate Tablets Market Size and Prospect (2021-2032)
    • 1.6.6 South America Afatinib Maleate Tablets Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Afatinib Maleate Tablets Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Boehringer Ingelheim International GmbH
    • 2.1.1 Boehringer Ingelheim International GmbH Details
    • 2.1.2 Boehringer Ingelheim International GmbH Major Business
    • 2.1.3 Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Product and Solutions
    • 2.1.4 Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Boehringer Ingelheim International GmbH Recent Developments and Future Plans
  • 2.2 Kelun-Kazpharm
    • 2.2.1 Kelun-Kazpharm Details
    • 2.2.2 Kelun-Kazpharm Major Business
    • 2.2.3 Kelun-Kazpharm Afatinib Maleate Tablets Product and Solutions
    • 2.2.4 Kelun-Kazpharm Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Kelun-Kazpharm Recent Developments and Future Plans
  • 2.3 Hansoh Pharmaceuticak
    • 2.3.1 Hansoh Pharmaceuticak Details
    • 2.3.2 Hansoh Pharmaceuticak Major Business
    • 2.3.3 Hansoh Pharmaceuticak Afatinib Maleate Tablets Product and Solutions
    • 2.3.4 Hansoh Pharmaceuticak Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Hansoh Pharmaceuticak Recent Developments and Future Plans
  • 2.4 Qilu Pharmaceutical
    • 2.4.1 Qilu Pharmaceutical Details
    • 2.4.2 Qilu Pharmaceutical Major Business
    • 2.4.3 Qilu Pharmaceutical Afatinib Maleate Tablets Product and Solutions
    • 2.4.4 Qilu Pharmaceutical Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Qilu Pharmaceutical Recent Developments and Future Plans
  • 2.5 Chia Tai-Tianqing
    • 2.5.1 Chia Tai-Tianqing Details
    • 2.5.2 Chia Tai-Tianqing Major Business
    • 2.5.3 Chia Tai-Tianqing Afatinib Maleate Tablets Product and Solutions
    • 2.5.4 Chia Tai-Tianqing Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Chia Tai-Tianqing Recent Developments and Future Plans
  • 2.6 Yangtze River Pharm
    • 2.6.1 Yangtze River Pharm Details
    • 2.6.2 Yangtze River Pharm Major Business
    • 2.6.3 Yangtze River Pharm Afatinib Maleate Tablets Product and Solutions
    • 2.6.4 Yangtze River Pharm Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Yangtze River Pharm Recent Developments and Future Plans
  • 2.7 Beacon Pharmaceuticals
    • 2.7.1 Beacon Pharmaceuticals Details
    • 2.7.2 Beacon Pharmaceuticals Major Business
    • 2.7.3 Beacon Pharmaceuticals Afatinib Maleate Tablets Product and Solutions
    • 2.7.4 Beacon Pharmaceuticals Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Beacon Pharmaceuticals Recent Developments and Future Plans
  • 2.8 Qingfeng Medicine Group
    • 2.8.1 Qingfeng Medicine Group Details
    • 2.8.2 Qingfeng Medicine Group Major Business
    • 2.8.3 Qingfeng Medicine Group Afatinib Maleate Tablets Product and Solutions
    • 2.8.4 Qingfeng Medicine Group Afatinib Maleate Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Qingfeng Medicine Group Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Afatinib Maleate Tablets Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Afatinib Maleate Tablets by Company Revenue
    • 3.2.2 Top 3 Afatinib Maleate Tablets Players Market Share in 2025
    • 3.2.3 Top 6 Afatinib Maleate Tablets Players Market Share in 2025
  • 3.3 Afatinib Maleate Tablets Market: Overall Company Footprint Analysis
    • 3.3.1 Afatinib Maleate Tablets Market: Region Footprint
    • 3.3.2 Afatinib Maleate Tablets Market: Company Product Type Footprint
    • 3.3.3 Afatinib Maleate Tablets Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Afatinib Maleate Tablets Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Afatinib Maleate Tablets Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Afatinib Maleate Tablets Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Afatinib Maleate Tablets Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Afatinib Maleate Tablets Consumption Value by Type (2021-2032)
  • 6.2 North America Afatinib Maleate Tablets Market Size by Application (2021-2032)
  • 6.3 North America Afatinib Maleate Tablets Market Size by Country
    • 6.3.1 North America Afatinib Maleate Tablets Consumption Value by Country (2021-2032)
    • 6.3.2 United States Afatinib Maleate Tablets Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Afatinib Maleate Tablets Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Afatinib Maleate Tablets Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Afatinib Maleate Tablets Consumption Value by Type (2021-2032)
  • 7.2 Europe Afatinib Maleate Tablets Consumption Value by Application (2021-2032)
  • 7.3 Europe Afatinib Maleate Tablets Market Size by Country
    • 7.3.1 Europe Afatinib Maleate Tablets Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Afatinib Maleate Tablets Market Size and Forecast (2021-2032)
    • 7.3.3 France Afatinib Maleate Tablets Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Afatinib Maleate Tablets Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Afatinib Maleate Tablets Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Afatinib Maleate Tablets Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Afatinib Maleate Tablets Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Afatinib Maleate Tablets Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Afatinib Maleate Tablets Market Size by Region
    • 8.3.1 Asia-Pacific Afatinib Maleate Tablets Consumption Value by Region (2021-2032)
    • 8.3.2 China Afatinib Maleate Tablets Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Afatinib Maleate Tablets Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Afatinib Maleate Tablets Market Size and Forecast (2021-2032)
    • 8.3.5 India Afatinib Maleate Tablets Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Afatinib Maleate Tablets Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Afatinib Maleate Tablets Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Afatinib Maleate Tablets Consumption Value by Type (2021-2032)
  • 9.2 South America Afatinib Maleate Tablets Consumption Value by Application (2021-2032)
  • 9.3 South America Afatinib Maleate Tablets Market Size by Country
    • 9.3.1 South America Afatinib Maleate Tablets Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Afatinib Maleate Tablets Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Afatinib Maleate Tablets Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Afatinib Maleate Tablets Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Afatinib Maleate Tablets Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Afatinib Maleate Tablets Market Size by Country
    • 10.3.1 Middle East & Africa Afatinib Maleate Tablets Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Afatinib Maleate Tablets Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Afatinib Maleate Tablets Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Afatinib Maleate Tablets Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Afatinib Maleate Tablets Market Drivers
  • 11.2 Afatinib Maleate Tablets Market Restraints
  • 11.3 Afatinib Maleate Tablets Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Afatinib Maleate Tablets Industry Chain
  • 12.2 Afatinib Maleate Tablets Upstream Analysis
  • 12.3 Afatinib Maleate Tablets Midstream Analysis
  • 12.4 Afatinib Maleate Tablets Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Afatinib Maleate Tablets. Industry analysis & Market Report on Afatinib Maleate Tablets is a syndicated market report, published as Global Afatinib Maleate Tablets Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Afatinib Maleate Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report